1 Min Read
June 6 (Reuters) - Galectin Therapeutics Inc
* Autoimmune disease patent granted to galectin therapeutics
* Galectin therapeutics inc says has been issued u.s. Patent 9,649,327 for "composition of novel carbohydrate drug for treatment of human diseases"
* Says patent coverage extends through 2032 Source text for Eikon: Further company coverage: